{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:11:00Z","timestamp":1788379860473,"version":"build-2803163510"},"reference-count":27,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DDDT"],"DOI":"10.2147\/dddt.s237301","type":"journal-article","created":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T21:06:12Z","timestamp":1589922372000},"page":"1963-1970","source":"Crossref","is-referenced-by-count":11,"title":["<p>Effects of Apatinib on the Pharmacokinetics of Nifedipine and Warfarin in Patients with Advanced Solid Tumors<\/p>"],"prefix":"10.2147","volume":"Volume 14","author":[{"given":"Yun-Ting","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zan","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9164-8309","authenticated-orcid":true,"given":"Yi-Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Xia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9645-7990","authenticated-orcid":true,"given":"Yun-Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Juan","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan-Ren","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Yuan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Fang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1517\/14656566.2015.981526","volume":"16","author":"Geng","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1080\/17474124.2016.1209407","volume":"10","author":"Roviello","year":"2016","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/jcph.1016","volume":"58","author":"Liu","year":"2018","journal-title":"J Clin Pharmacol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1124\/dmd.112.050310","volume":"41","author":"Ding","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol Ther"},{"key":"ref6","unstructured":"Choueiri TK, Sonpavde G, Goldberg RM, Larson RA, Tirnauer JS Toxicity of molecularly targeted antiangiogenic agents: non-cardiovascular effects. UpToDate [homepage on the Internet]; 2014. Available from: https:\/\/www.uptodate.com\/contents\/zh-Hans\/toxicity-of-molecularly-targeted-antiangiogenic-agents-non-cardiovascular-effects.html. Accessed 19 July, 2019."},{"key":"ref7","unstructured":"US Food and Drug Administration: Center for Drug Evaluation and Research (CDER). Guidance for Industry: Clinical Drug Interaction Studies\u2014study Design, Data Analysis, and Clinical Implications (Draft). US Food and Drug Administration; 2017."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1177\/1078155218801061","volume":"25","author":"Hiraide","year":"2019","journal-title":"J Oncol Pharm Pract"},{"key":"ref9","first-page":"360","volume":"54","author":"Chen","year":"2019","journal-title":"Yao Xue Xue Bao"},{"key":"ref10","first-page":"105","volume":"47","author":"Jin","year":"2012","journal-title":"Yao Xue Xue Bao"},{"key":"ref11","unstructured":"US Food and Drug Administration: Center for Drug Evaluation and Research (CDER). Guidance for Industry: In Vitro Metabolism- and Transporter-Mediated Drug-Drug Interaction Studies (Draft). US Food and Drug Administration; 2017."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/1471-2407-10-529","volume":"10","author":"Li","year":"2010","journal-title":"BMC Cancer"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s40262-016-0427-y","volume":"56","author":"Yu","year":"2017","journal-title":"Clin Pharmacokinet"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1080\/00498250902846252","volume":"39","author":"Tachibana","year":"2009","journal-title":"Xenobiotica"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/clpt.2014.43","volume":"95","author":"Vieira","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1046\/j.1365-2125.2003.01789.x","volume":"55","author":"Lang","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1111\/bcp.13226","volume":"83","author":"Filgueira","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1161\/HYPERTENSIONAHA.117.08856","volume":"70","author":"Touyz","year":"2017","journal-title":"Hypertension"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3109\/0284186X.2010.543696","volume":"50","author":"Bono","year":"2011","journal-title":"Acta Oncol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1365-2125.2011.04051.x","volume":"73","author":"Lane","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1365-2125.2012.04335.x","volume":"75","author":"Maddison","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/jcph.813","volume":"57","author":"Flora","year":"2017","journal-title":"J Clin Pharmacol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s40291-016-0247-7","volume":"21","author":"Shaul","year":"2017","journal-title":"Mol Diagn Ther"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.2146\/ajhp080436","volume":"66","author":"Moretti","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1177\/1078155216677853","volume":"24","author":"Primeaux","year":"2018","journal-title":"J Oncol Pharm Pract"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40780-016-0050-y","volume":"2","author":"Kitade","year":"2016","journal-title":"J Pharma Health Care Sci"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1016\/j.xphs.2016.03.011","volume":"105","author":"Shaik","year":"2016","journal-title":"J Pharm Sci"}],"container-title":["Drug Design, Development and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=58261","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=58261","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T21:06:19Z","timestamp":1589922379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/effects-of-apatinib-on-the-pharmacokinetics-of-nifedipine-and-warfarin-peer-reviewed-article-DDDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":27,"URL":"https:\/\/doi.org\/10.2147\/dddt.s237301","relation":{},"ISSN":["1177-8881"],"issn-type":[{"value":"1177-8881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}